Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse

James P Morgan, MD, PhD
Section Editors
William J McKenna, MD
Stephen J Traub, MD
Deputy Editor
Brian C Downey, MD, FACC


Cocaine is among the most commonly used illicit recreational drugs worldwide. Because even casual use of cocaine may be associated with acute or chronic cardiovascular toxicity, the large numbers of exposed individuals may present with sequelae related to the cardiovascular system. Thus, the cardiovascular history should include questions about cocaine use, specifically focusing on symptoms associated with ischemic heart disease.

Cocaine use is more frequently associated with acute rather than chronic cardiovascular illness. Among cocaine users who present to emergency departments, cardiovascular complaints, particularly chest pain, are common [1,2]. In such patients, acute coronary syndromes (including myocardial ischemia and infarction), aortic dissection and rupture, arrhythmias, myocarditis, and vasculitis need to be considered [3].

The cardiovascular effects and complications of cocaine use, as well as the management of cocaine-associated ischemia, will be reviewed here. Other issues relating to cocaine use, including the general approach to patients with chest pain and a history of cocaine use, are discussed elsewhere. (See "Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis" and "Cocaine: Acute intoxication".)


The major cardiovascular effects of cocaine appear to be caused by the inhibition of norepinephrine reuptake into the synaptic cleft by sympathetic neurons, although sodium channel blockade and stimulation of excitatory amino acids likely also contribute to the effects [2]. Since reuptake is the major mechanism by which neurotransmitters are removed from active receptor sites, this inhibition results in potentiation of the response to sympathetic stimulation of innervated organs and to infused catecholamine. Cocaine may also enhance the release of catecholamines from central and peripheral stores [4,5]. The ensuing sympathomimetic actions (increased myocardial inotropy, heart rate, systemic blood pressure, and coronary artery constriction primarily at the capillary level) are mediated by stimulation of the alpha- and beta-adrenergic receptors and result in increased myocardial oxygen demand and decreased myocardial perfusion. (See "Cocaine: Acute intoxication", section on 'Pathophysiology'.)

Other cardiovascular effects of cocaine include promotion of thrombus formation (via activation of platelets, stimulation of platelet aggregability, and potentiation of thromboxane production) and proarrhythmia [6-8]. The cardiovascular effects produced by intravenous, intranasal, and inhaled cocaine are thought to be similar regardless of the route of ingestion.

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 25, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001; 345:351.
  2. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation 2010; 122:2558.
  3. Krendel DA, Ditter SM, Frankel MR, Ross WK. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology 1990; 40:1092.
  4. Maraj S, Figueredo VM, Lynn Morris D. Cocaine and the heart. Clin Cardiol 2010; 33:264.
  5. Gurudevan SV, Nelson MD, Rader F, et al. Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography. Circulation 2013; 128:598.
  6. Togna G, Tempesta E, Togna AR, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis 1985; 15:100.
  7. Kugelmass AD, Shannon RP, Yeo EL, Ware JA. Intravenous cocaine induces platelet activation in the conscious dog. Circulation 1995; 91:1336.
  8. Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000; 83:688.
  9. Lange RA, Willard JE. The cardiovascular effects of cocaine. Heart Dis Stroke 1993; 2:136.
  10. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008; 117:1897.
  11. Carrillo X, Curós A, Muga R, et al. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes. Eur Heart J 2011; 32:1244.
  12. Qureshi AI, Suri MF, Guterman LR, Hopkins LN. Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey. Circulation 2001; 103:502.
  13. Mittleman MA, Mintzer D, Maclure M, et al. Triggering of myocardial infarction by cocaine. Circulation 1999; 99:2737.
  14. Kolodgie FD, Wilson PS, Cornhill JF, et al. Increased prevalence of aortic fatty streaks in cholesterol-fed rabbits administered intravenous cocaine: the role of vascular endothelium. Toxicol Pathol 1993; 21:425.
  15. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 1990; 65:303.
  16. Clinical policy for the initial approach to adults presenting with a chief complaint of chest pain, with no history of trauma. American College of Emergency Physicians. Ann Emerg Med 1995; 25:274.
  17. Hollander JE, Brooks DE, Valentine SM. Assessment of cocaine use in patients with chest pain syndromes. Arch Intern Med 1998; 158:62.
  18. Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med 1992; 10:169.
  19. Isner JM, Estes NA 3rd, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315:1438.
  20. Goldfrank LR, Hoffman RS. The cardiovascular effects of cocaine. Ann Emerg Med 1991; 20:165.
  21. Minor RL Jr, Scott BD, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115:797.
  22. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995; 333:1267.
  23. Bertolet BD, Freund G, Martin CA, et al. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol 1990; 13:323.
  24. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989; 321:1557.
  25. Vitullo JC, Karam R, Mekhail N, et al. Cocaine-induced small vessel spasm in isolated rat hearts. Am J Pathol 1989; 135:85.
  26. Kalsner S. Cocaine sensitization of coronary artery contractions: mechanism of drug-induced spasm. J Pharmacol Exp Ther 1993; 264:1132.
  27. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol 2007; 100:1040.
  28. Wang SY, Nunez BD, Morgan JP, et al. Cocaine and the porcine coronary microcirculation: effects of chronic cocaine exposure and hypercholesterolemia. J Cardiothorac Vasc Anesth 1995; 9:290.
  29. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group. Acad Emerg Med 1994; 1:330.
  30. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation 2002; 105:1592.
  31. Dean JH, Woznicki EM, O'Gara P, et al. Cocaine-related aortic dissection: lessons from the International Registry of Acute Aortic Dissection. Am J Med 2014; 127:878.
  32. Satran A, Bart BA, Henry CR, et al. Increased prevalence of coronary artery aneurysms among cocaine users. Circulation 2005; 111:2424.
  33. Waller BF. Chapter 55. Nonatherosclerotic Coronary Heart Disease.. In: Hurst's The Heart, 13th, Fuster V, O'Rourke RA, Walsh RA, et al. (Eds), McGraw-Hill, 2010.
  34. Glickel SZ, Maggs PR, Ellis FH Jr. Coronary artery aneurysm. Ann Thorac Surg 1978; 25:372.
  35. Kloner RA, Hale S, Alker K, Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation 1992; 85:407.
  36. Peng SK, French WJ, Pelikan PC. Direct cocaine cardiotoxicity demonstrated by endomyocardial biopsy. Arch Pathol Lab Med 1989; 113:842.
  37. Virmani R, Robinowitz M, Smialek JE, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 1988; 115:1068.
  38. Hogya PT, Wolfson AB. Chronic cocaine abuse associated with dilated cardiomyopathy. Am J Emerg Med 1990; 8:203.
  39. Isner JM, Chokshi SK. Cardiovascular complications of cocaine. Curr Probl Cardiol 1991; 16:89.
  40. Wiener RS, Lockhart JT, Schwartz RG. Dilated cardiomyopathy and cocaine abuse. Report of two cases. Am J Med 1986; 81:699.
  41. Willens HJ, Chakko SC, Kessler KM. Cardiovascular manifestations of cocaine abuse. A case of recurrent dilated cardiomyopathy. Chest 1994; 106:594.
  42. Fineschi V, Silver MD, Karch SB, et al. Myocardial disarray: an architectural disorganization linked with adrenergic stress? Int J Cardiol 2005; 99:277.
  43. Ren S, Tong W, Lai H, et al. Effect of long-term cocaine use on regional left ventricular function as determined by magnetic resonance imaging. Am J Cardiol 2006; 97:1085.
  44. Arora S, Alfayoumi F, Srinivasan V. Transient left ventricular apical ballooning after cocaine use: is catecholamine cardiotoxicity the pathologic link? Mayo Clin Proc 2006; 81:829.
  45. Henzlova MJ, Smith SH, Prchal VM, Helmcke FR. Apparent reversibility of cocaine-induced congestive cardiomyopathy. Am Heart J 1991; 122:577.
  46. Om A, Ellahham S, Ornato JP. Reversibility of cocaine-induced cardiomyopathy. Am Heart J 1992; 124:1639.
  47. Chokshi SK, Moore R, Pandian NG, Isner JM. Reversible cardiomyopathy associated with cocaine intoxication. Ann Intern Med 1989; 111:1039.
  48. Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol 1994; 34:902.
  49. Om A, Ellenbogen KA, Vetrovec GW. Cocaine-induced bradyarrhythmias. Am Heart J 1992; 124:232.
  50. Schrem SS, Belsky P, Schwartzman D, Slater W. Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndrome. Am Heart J 1990; 120:980.
  51. Nanji AA, Filipenko JD. Asystole and ventricular fibrillation associated with cocaine intoxication. Chest 1984; 85:132.
  52. Littmann L, Monroe MH, Svenson RH. Brugada-type electrocardiographic pattern induced by cocaine. Mayo Clin Proc 2000; 75:845.
  53. Magnano AR, Talathoti NB, Hallur R, et al. Effect of acute cocaine administration on the QTc interval of habitual users. Am J Cardiol 2006; 97:1244.
  54. Hsue PY, McManus D, Selby V, et al. Cardiac arrest in patients who smoke crack cocaine. Am J Cardiol 2007; 99:822.
  55. Haigney MC, Alam S, Tebo S, et al. Intravenous cocaine and QT variability. J Cardiovasc Electrophysiol 2006; 17:610.
  56. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006; 29:1130.
  57. Tisdale JE, Shimoyama H, Sabbah HN, Webb CR. The effect of cocaine on Ventricular fibrillation threshold in the normal canine heart. Pharmacotherapy 1996; 16:429.
  58. Petitti DB, Sidney S, Quesenberry C, Bernstein A. Stroke and cocaine or amphetamine use. Epidemiology 1998; 9:596.
  59. Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol 1989; 46:989.
  60. Kaufman MJ, Levin JM, Maas LC, et al. Cocaine decreases relative cerebral blood volume in humans: a dynamic susceptibility contrast magnetic resonance imaging study. Psychopharmacology (Berl) 1998; 138:76.
  61. Johnson B, Lamki L, Fang B, et al. Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 1998; 18:377.
  62. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke 1995; 26:1114.
  63. Martínez N, Díez-Tejedor E, Frank A. Vasospasm/thrombus in cerebral ischemia related to cocaine abuse. Stroke 1996; 27:147.
  64. Dabbouseh NM, Ardelt A. Cocaine mediated apoptosis of vascular cells as a mechanism for carotid artery dissection leading to ischemic stroke. Med Hypotheses 2011; 77:201.
  65. Robinson JE, Heaton RK, O'Malley SS. Neuropsychological functioning in cocaine abusers with and without alcohol dependence. J Int Neuropsychol Soc 1999; 5:10.
  66. Johnson BA, Devous MD Sr, Ruiz P, Ait-Daoud N. Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. Am J Psychiatry 2001; 158:1191.
  67. Brickner ME, Willard JE, Eichhorn EJ, et al. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation 1991; 84:1130.
  68. Anderson J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College or Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:e1 www.acc.org/qualityandscience/clinical/statements.htm (Accessed on September 18, 2007).
  69. McLaurin M, Apple FS, Henry TD, Sharkey SW. Cardiac troponin I and T concentrations in patients with cocaine-associated chest pain. Ann Clin Biochem 1996; 33 ( Pt 3):183.
  70. Hollander JE, Levitt MA, Young GP, et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J 1998; 135:245.
  71. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:2354.
  72. American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O'Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61:e78.
  73. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med 2003; 21:39.
  74. Baumann BM, Perrone J, Hornig SE, et al. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med 2000; 7:878.
  75. Richards JR, Lange RA, Arnold TC, Horowitz BZ. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol. Am J Emerg Med 2017; 35:519.e1.
  76. Öcal L, Çakir H, Tellice M, et al. Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy. Herz 2015; 40:159.
  77. Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review. Clin Toxicol (Phila) 2016; 54:345.
  78. Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008; 51:127.
  79. Richards JR, Hollander JE, Ramoska EA, et al. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon. J Cardiovasc Pharmacol Ther 2017; 22:239.
  80. Hollander JE, Hoffman RS, Burstein JL, et al. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med 1995; 155:1081.
  81. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990; 112:897.
  82. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993; 94:608.
  83. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 1991; 9:161.
  84. Fareed FN, Chan G, Hoffman RS. Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol 2007; 3:169.
  85. Mohamad T, Kondur A, Vaitkevicius P, et al. Cocaine-induced chest pain and beta-blockade: an inner city experience. Am J Ther 2008; 15:531.
  86. Richards DA, Prichard BN, Boakes AJ, et al. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J 1977; 39:99.
  87. Chan GM, Sharma R, Price D, et al. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). J Med Toxicol 2006; 2:108.
  88. Dattilo PB, Hailpern SM, Fearon K, et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 2008; 51:117.
  89. Rangel C, Shu RG, Lazar LD, et al. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med 2010; 170:874.
  90. Ibrahim M, Maselli DJ, Hasan R, Hamilton A. Safety of β-blockers in the acute management of cocaine-associated chest pain. Am J Emerg Med 2013; 31:613.
  91. Fanari Z, Kennedy KK, Lim MJ, et al. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain. Am J Cardiol 2014; 113:1802.
  92. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61:e179.
  93. Armstrong LE, Crago AE, Adams R, et al. Whole-body cooling of hyperthermic runners: comparison of two field therapies. Am J Emerg Med 1996; 14:355.
  94. Costrini A. Emergency treatment of exertional heatstroke and comparison of whole body cooling techniques. Med Sci Sports Exerc 1990; 22:15.
  95. Gupta N, Washam JB, Mountantonakis SE, et al. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry). Am J Cardiol 2014; 113:749.
  96. Hollander JE, Wilson LD, Leo PJ, Shih RD. Complications from the use of thrombolytic agents in patients with cocaine associated chest pain. J Emerg Med 1996; 14:731.
  97. Lemos PA. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis? Catheter Cardiovasc Interv 2007; 69:959.
  98. McKee SA, Applegate RJ, Hoyle JR, et al. Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention. Am Heart J 2007; 154:159.
  99. Hollander JE, Hoffman RS, Gennis P, et al. Cocaine-associated chest pain: one-year follow-up. Acad Emerg Med 1995; 2:179.